In a report released on March 11, Justine Telliez from Kepler Capital maintained a Buy rating on Genfit (GNFTF – Research Report), with a ...

HERZLIYA, Israel and CALGARY, AB, Feb. 27, 2025 /PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the "Company" or "Innocan") is pleased ...

Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) today announced that members of its executive team will present and host 1x1 meetings at the Leerink Partners 2025 ...

MARSEILLE, France, February 27, 2025--(BUSINESS WIRE)--Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company") today announced that members of its ...

MARSEILLE, France--(BUSINESS WIRE)--Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) today announced that members of its executive team will present ...

Javascript is required for you to be able to read premium content. Please enable it in your browser settings.

87.4% of bluebird bio shares are held by institutional investors. Comparatively, 0.2% of Innate Pharma shares are held by institutional investors. 1.4% of bluebird bio shares are held by company ...

Cosette Pharmaceuticals, based in Bridgewater, N.J., with a pharmaceutical production plant in Lincolnton, N.C., will acquire the Australian pharmaceutical company Mayne Pharma Group, which has its ...

Innate Pharma (IPHA) had recently received Breakthrough Therapy Designation [BTD] for its anti-KIR3DL2 antibody candidate known as lacutamab. This particular antibody is being developed for the ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...